180 Life Sciences Corp. 8-K Report: Insights on Common Stock & Warrants - Feb 2025

$ATNF
Form 8-K
Filed on: 2025-02-21
Source
180 Life Sciences Corp. 8-K Report: Insights on Common Stock & Warrants - Feb 2025

Based on the provided financial report section, here are the key insights extracted:

  1. Entity Information:
  • Company Name: 180 Life Sciences Corp.
  • CIK Number: 0001690080
  • Registration Number: 001-38105
  • EIN: 90-1890354
  • Address: 3000 El Camino Real Bldg. 4 Suite 200, Palo Alto, CA 94306
  • Phone Number: 650-507-0669
  1. Filing Type:
  • Form Type: 8-K
  • Filing Date: February 15, 2025
  1. Stock Information:
  • Common Stock:
    • Par value: $0.0001 per share
    • Ticker Symbol: ATNF (listed on NASDAQ)
  • Warrants:
    • Ticker Symbol for Warrants: ATNFW (also listed on NASDAQ)
  1. Context Details:
  • The report pertains to the date of February 15, 2025.
  • It includes details related to "Common Stock" and "Warrants to Purchase Shares of Common Stock."
  1. Units of Measure:
  • The financial data is presented in U.S. Dollars (USD) and shares.
  1. Key Dates:
  • The effective date of the report is February 15, 2025, which is also the start and end date for the periods mentioned.

Insights:

  • The company is actively reporting developments related to its equity securities, specifically its common stock and warrants.
  • The par value of the common stock is relatively low, which may suggest a strategic pricing approach, potentially making it appealing for investors.
  • Being listed on NASDAQ indicates that the company is subject to rigorous financial reporting and compliance standards, which can enhance credibility with investors.
  • The presence of warrants indicates that the company may be offering opportunities for investors to purchase additional shares in the future, which could impact future capital structure and stock performance.

Overall, this financial report section reflects significant corporate actions and the status of equity securities that may be relevant to current and prospective investors.